If blood vessels are severely damaged or the heart valves no longer function properly, replacements are needed. These life-saving devices are usually made of synthetic materials. Whilst these materials have many advantages, they have one major drawback when they come into contact with blood: they often trigger clotting, which can lead to blood clots forming on their surface. If these break loose, they can lead to life-threatening complications such as thrombosis or embolism. As a result, patients with such implants often have to take anticoagulants for the rest of their lives and suffer from their side effects.
German researchers have now developed a new approach to solving these problems in the form of nanostructured polymer surfaces. These feature extremely fine, highly ordered surface patterns, whose polymer crystals are only a few tens of billionths of a metre in size.
The key point here is that these ordered patterns are roughly the same size as the fibrinogen protein molecule, which plays a key role in blood clotting. Owing to this size match and physical forces, the fibrinogen aligns itself along the patterns. When platelets – which are also important in blood clotting – are brought into contact with pre-treated, fibrinogen-coated polymer patterns, they usually undergo changes. However, these changes depend heavily on the structure of the polymer patterns. Using this new surface, platelet activation can now be engineered in such a way as to prevent the formation of thrombi.
References:
Friedrich Schiller University Jena
How Nanotopography-Induced Conformational Changes of Fibrinogen Affect Platelet Adhesion and Activation, Langmuir 2020; https://doi.org/10.1021/acs.langmuir.0c02094